Ghobrial, I. M., Campigotto, F., Murphy, T. J., Boswell, E. N., Banwait, R., Azab, F., . . . Matous, J. (2013). Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia. American Society of Hematology.
Citação norma ChicagoGhobrial, Irene M., et al. Results of a Phase 2 Trial of the Single-agent Histone Deacetylase Inhibitor Panobinostat in Patients With Relapsed/refractory Waldenström Macroglobulinemia. American Society of Hematology, 2013.
Citação norma MLAGhobrial, Irene M., et al. Results of a Phase 2 Trial of the Single-agent Histone Deacetylase Inhibitor Panobinostat in Patients With Relapsed/refractory Waldenström Macroglobulinemia. American Society of Hematology, 2013.